RepliCel Life Sciences Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was CAD 597,994 compared to CAD 589,550 a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago. For the nine months, net loss was CAD 1.325 million compared to CAD 2.377 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.08 a year ago.